Loading...
Loading...
Genenta Science S.p.A.
Genenta Science S.p.A.. Spoken Alpha tracks GNTA's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks GNTA's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 8/10 quarters but stock falls 60% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for GNTA.
curl https://api.spokenalpha.com/v1/companies/GNTA| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.68 | $1.51 | +11.1% | -6.2% | -7.0% |
| Q4 FY2026 | $1.77 | $1.61 | +9.8% | +4.2% | +6.1% |
| Q3 FY2026 | $1.65 | $1.64 | +0.7% | -2.7% | -5.0% |
| Q2 FY2026 | $1.63 | $1.56 | +4.4% | +2.9% | +4.9% |
| Q1 FY2025 | $1.56 | $1.58 | -1.5% | -3.3% | -1.6% |
| Q4 FY2025 | $1.51 | $1.52 | -0.4% | -2.6% | -4.7% |
| Q3 FY2025 | $1.63 | $1.54 | +5.7% | -1.4% | -3.2% |
| Q2 FY2025 | $1.75 | $1.59 | +9.9% | +2.8% | +2.2% |
| Q1 FY2024 | $1.76 | $1.55 | +13.5% | -4.7% | -4.8% |
| Q4 FY2024 | $1.80 | $1.68 | +6.9% | +1.2% | +1.9% |